Journal of General Virology, Vol 80, 399-408, Copyright © 1999 by Society for General Microbiology

ARTICLES

Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. I. Differential T-helper and IgG responses in relation to HPV infection and disease outcome

TD de Gruijl, HJ Bontkes, JM Walboomers, P Coursaget, MJ Stukart, C Dupuy, E Kueter, RH Verheijen, TJ Helmerhorst, MF Duggan-Keen, PL Stern, CJ Meijer and RJ Scheper
Department of Pathology, Free University Hospital, Amsterdam, The Netherlands.

T-helper (Th) cell-dependent IL-2 production and plasma IgG responses to virus-like particles consisting of the human papillomavirus type 16 (HPV-16) major capsid protein L1 (L1-VLP) were determined in patients with cytological evidence of cervical intraepithelial neoplasia (CIN) participating in a non-intervention prospective cohort study. IgG responses were associated with HPV-16 persistence and high-grade CIN lesions, while high frequencies of Th responses were observed in patients with both virus clearance and virus persistence, irrespective of CIN grade. The IgG response was found in conjunction with an IL-2 response to L1-VLP in 87% of the patients. Recognition of the HPV-16 L1 Th epitope (amino acids 311-335) was found to be more closely associated than recognition of L1-VLP as a whole to HPV exposure and CIN development. Among the HPV-16+ patients included in this study, those showing a Th response to amino acids 311-335 were more likely to carry the HLA DRB1*11/DQB1*0301 haplotype, while those showing an IgG response to L1-VLP were more likely to carry DRB1*0101/DQB1*0501. However, neither cell-mediated nor humoral immune responses against HPV- 16 L1 appear to be sufficient for the natural control of HPV infection and CIN development.

This article has been cited by other articles:

				M. M. Madeleine, L. G. Johnson, A. G. Smith, J. A. Hansen, B. B. Nisperos, S. Li, L.-P. Zhao, J. R. Daling, S. M. Schwartz, and D. A. Galloway Comprehensive Analysis of HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 Loci and Squamous Cell Cervical Cancer Risk Cancer Res., May 1, 2008; 68(9): 3532 - 3539. [Abstract] [Full Text] [PDF]

				Z. Z. A. Mbulawa, A.-L. Williamson, D. Stewart, J.-A. S. Passmore, L. Denny, B. Allan, and D. J. Marais Association of serum and mucosal neutralizing antibodies to human papillomavirus type 16 (HPV-16) with HPV-16 infection and cervical disease J. Gen. Virol., April 1, 2008; 89(4): 910 - 914. [Abstract] [Full Text] [PDF]

				M. J. J. Fleury, A. Touze, S. de Sanjose, F. X. Bosch, J. Klaustermeiyer, and P. Coursaget Detection of Human Papillomavirus Type 31-Neutralizing Antibodies from Naturally Infected Patients by an Assay Based on Intracellular Assembly of Luciferase-Expressing Pseudovirions Clin. Vaccine Immunol., January 1, 2008; 15(1): 172 - 175. [Abstract] [Full Text] [PDF]

				E. P. Ryan, C. M. Malboeuf, M. Bernard, R. C. Rose, and R. P. Phipps Cyclooxygenase-2 Inhibition Attenuates Antibody Responses against Human Papillomavirus-Like Particles J. Immunol., December 1, 2006; 177(11): 7811 - 7819. [Abstract] [Full Text] [PDF]

				A. J. Garcia-Pineres, A. Hildesheim, R. Herrero, M. Trivett, M. Williams, I. Atmetlla, M. Ramirez, M. Villegas, M. Schiffman, A. C. Rodriguez, et al. Persistent Human Papillomavirus Infection Is Associated with a Generalized Decrease in Immune Responsiveness in Older Women. Cancer Res., November 15, 2006; 66(22): 11070 - 11076. [Abstract] [Full Text] [PDF]

				G. Y. F. Ho, Y. Y. Studentsov, R. Bierman, and R. D. Burk Natural History of Human Papillomavirus Type 16 Virus-Like Particle Antibodies in Young Women Cancer Epidemiol. Biomarkers Prev., January 1, 2004; 13(1): 110 - 116. [Abstract] [Full Text] [PDF]

				J. C. Luxton, R. Nath, N. Derias, A. Herbert, and P. S. Shepherd Human papillomavirus type 16-specific T cell responses and their association with recurrence of cervical disease following treatment J. Gen. Virol., May 1, 2003; 84(5): 1063 - 1070. [Abstract] [Full Text] [PDF]

				O. M. Williams, K. W. Hart, E. C. Y. Wang, and C. M. Gelder Analysis of CD4+ T-Cell Responses to Human Papillomavirus (HPV) Type 11 L1 in Healthy Adults Reveals a High Degree of Responsiveness and Cross-Reactivity with Other HPV Types J. Virol., June 27, 2002; 76(15): 7418 - 7429. [Abstract] [Full Text] [PDF]

				R. T. Emeny, C. M. Wheeler, K. U. Jansen, W. C. Hunt, T.-M. Fu, J. F. Smith, S. MacMullen, M. T. Esser, and X. Paliard Priming of Human Papillomavirus Type 11-Specific Humoral and Cellular Immune Responses in College-Aged Women with a Virus-Like Particle Vaccine J. Virol., June 27, 2002; 76(15): 7832 - 7842. [Abstract] [Full Text] [PDF]

				L. Bousarghin, A.-L. Combita-Rojas, A. Touze, S. El Mehdaoui, P.-Y. Sizaret, M.-M. Bravo, and P. Coursaget Detection of Neutralizing Antibodies against Human Papillomaviruses (HPV) by Inhibition of Gene Transfer Mediated by HPV Pseudovirions J. Clin. Microbiol., March 1, 2002; 40(3): 926 - 932. [Abstract] [Full Text] [PDF]

				A. Touze, S. de Sanjose, P. Coursaget, M. R. Almirall, V. Palacio, C. J. L. M. Meijer, J. Kornegay, and F. X. Bosch Prevalence of Anti-Human Papillomavirus Type 16, 18, 31, and 58 Virus-Like Particles in Women in the General Population and in Prostitutes J. Clin. Microbiol., December 1, 2001; 39(12): 4344 - 4348. [Abstract] [Full Text] [PDF]

				H. Bontkes, T. de Gruijl, J. Walboomers, J. Schiller, J Dillner, T. Helmerhorst, R. Verheijen, R. Scheper, and C. Meijer Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16 J. Gen. Virol., February 1, 1999; 80(2): 409 - 417. [Abstract]